Global Human Microbiome market cagr 14.3%

Human Microbiome Market

Human Microbiome Market Scope: Industry

Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Human Microbiome Market Size and Growth

The global human microbiome market is experiencing rapid growth due to increasing research and development activities in the field of microbiome therapeutics. The market size is estimated to be worth over $700 million and is projected to reach $1.7 billion by 2025. Rising prevalence of chronic diseases and growing awareness about the importance of gut health are driving market expansion. Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Vedanta

◍ Seres Therapeutics

◍ Second Genome

◍ Rebiotix

◍ ActoGeniX

◍ Enterome BioScience

◍ AvidBiotics

◍ 4D Pharma Research Ltd

◍ Enterologics

◍ Metabogen

◍ Metabiomics

◍ Ritter Pharmaceuticals

◍ Osel

◍ Symberix

◍ Miomics

◍ Symbiotix Biotherapies

◍ MicroBiome Therapeutics LLC

The competitive landscape of the human microbiome market is diverse with companies such as Vedanta, Seres Therapeutics, Second Genome, Rebiotix, and others leading the way in developing microbiome-based therapeutics and diagnostics. These companies leverage the human microbiome to address various health conditions and drive growth in the market.

- Vedanta Biosciences: Sales revenue of $10 million

- Seres Therapeutics: Sales revenue of $30 million

- Second Genome: Sales revenue of $15 million